Alaska Permanent Fund Corp Makes New $4.57 Million Investment in Humana Inc. (NYSE:HUM)

Alaska Permanent Fund Corp acquired a new position in shares of Humana Inc. (NYSE:HUM) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 9,989 shares of the insurance provider’s stock, valued at approximately $4,573,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Mariner LLC raised its stake in shares of Humana by 2.3% in the third quarter. Mariner LLC now owns 14,119 shares of the insurance provider’s stock worth $6,869,000 after acquiring an additional 312 shares during the last quarter. Massachusetts Financial Services Co. MA grew its holdings in Humana by 27.5% during the third quarter. Massachusetts Financial Services Co. MA now owns 27,943 shares of the insurance provider’s stock valued at $13,595,000 after purchasing an additional 6,034 shares during the period. Silverarc Capital Management LLC acquired a new position in Humana during the third quarter valued at approximately $4,865,000. Vest Financial LLC grew its holdings in Humana by 43.3% during the fourth quarter. Vest Financial LLC now owns 27,993 shares of the insurance provider’s stock valued at $12,815,000 after purchasing an additional 8,455 shares during the period. Finally, Artemis Investment Management LLP lifted its stake in Humana by 9.6% in the fourth quarter. Artemis Investment Management LLP now owns 64,573 shares of the insurance provider’s stock valued at $29,563,000 after buying an additional 5,672 shares in the last quarter. 92.38% of the stock is owned by institutional investors.

Humana Stock Down 1.7 %

NYSE:HUM traded down $5.36 during trading hours on Thursday, hitting $310.62. 261,939 shares of the company traded hands, compared to its average volume of 1,984,208. The company has a quick ratio of 1.59, a current ratio of 1.59 and a debt-to-equity ratio of 0.63. The firm’s 50-day simple moving average is $329.24 and its 200-day simple moving average is $396.94. Humana Inc. has a one year low of $299.23 and a one year high of $541.21. The company has a market cap of $37.48 billion, a PE ratio of 15.95, a PEG ratio of 1.92 and a beta of 0.45.

Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, April 24th. The insurance provider reported $7.23 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.12 by $1.11. Humana had a return on equity of 19.44% and a net margin of 2.34%. The business had revenue of $29.61 billion for the quarter, compared to analysts’ expectations of $28.52 billion. During the same period in the previous year, the business posted $9.38 EPS. The firm’s quarterly revenue was up 10.7% compared to the same quarter last year. Equities analysts predict that Humana Inc. will post 16.06 earnings per share for the current year.

Humana Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 26th. Stockholders of record on Friday, June 28th will be issued a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a dividend yield of 1.14%. The ex-dividend date is Friday, June 28th. Humana’s payout ratio is 17.86%.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on the stock. Argus lowered shares of Humana from a “buy” rating to a “hold” rating in a research report on Wednesday, March 13th. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $391.00 price target on shares of Humana in a research report on Wednesday, April 10th. Truist Financial reaffirmed a “hold” rating and set a $550.00 price target on shares of Humana in a research report on Friday, January 19th. Oppenheimer dropped their price target on shares of Humana from $415.00 to $370.00 and set an “outperform” rating on the stock in a research report on Thursday. Finally, Barclays dropped their price target on shares of Humana from $356.00 to $310.00 and set an “equal weight” rating on the stock in a research report on Tuesday, April 2nd. Eleven equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. According to data from MarketBeat, Humana currently has an average rating of “Hold” and an average target price of $440.95.

Insiders Place Their Bets

In other news, Director Jorge S. Mesquita bought 545 shares of the business’s stock in a transaction on Tuesday, February 20th. The stock was acquired at an average price of $367.09 per share, with a total value of $200,064.05. Following the completion of the purchase, the director now directly owns 2,578 shares in the company, valued at $946,358.02. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.32% of the stock is owned by insiders.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.